Targeting gene expression to hypoxic tumor cells
- 1 May 1997
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 3 (5) , 515-520
- https://doi.org/10.1038/nm0597-515
Abstract
Solid tumors with areas of low oxygen tension (hypoxia) have a poor prognosis, as celts in this environment often survive radiation and chemotherapy. In this report we describe how this hypoxic environment can be used to activate heterologous gene expression driven by a hypoxia-responsive element (HRE), which interacts with the transcriptional complex hypoxia-inducible factor-1 (HIF-1). Our results demonstrate that the HIF-1/HRE system of gene regulation is active in hypoxic tumor cells and show the potential of exploiting tumor-specific conditions for the targeted expression of diagnostic or therapeutic genes in cancer therapy.Keywords
This publication has 24 references indexed in Scilit:
- Oxygen sensing and molecular adaptation to hypoxiaPhysiological Reviews, 1996
- IntroductionSeminars in Radiation Oncology, 1996
- Spatial and temporal control of gene therapy using ionizing radiationNature Medicine, 1995
- Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.Proceedings of the National Academy of Sciences, 1995
- Tissue-Specific Targeting of Retroviral Vectors Through Ligand-Receptor InteractionsScience, 1994
- Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3' enhancer.Proceedings of the National Academy of Sciences, 1994
- General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia.Proceedings of the National Academy of Sciences, 1993
- Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system.Proceedings of the National Academy of Sciences, 1992
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.Journal of Clinical Oncology, 1989